Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Bliss GVS Pharma Dividend Announcement
• Bliss GVS Pharma announced a annually dividend of ₹0.50 per ordinary share which will be made payable on 2024-08-24. Ex dividend date: 2024-07-18
• Bliss GVS Pharma annual dividend for 2024 was ₹0.50
• Bliss GVS Pharma annual dividend for 2023 was ₹0.50
• Bliss GVS Pharma's trailing twelve-month (TTM) dividend yield is 0.32%
• Bliss GVS Pharma's dividend growth over the last five years (2018-2023) was -12.94% year
• Bliss GVS Pharma's dividend growth over the last ten years (2013-2023) was -3.31% year
Bliss GVS Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-18 | ₹0.50 | annually | 2024-08-24 |
2023-07-12 | ₹0.50 | annually | 2023-08-18 |
2022-06-20 | ₹0.50 | annually | 2022-07-28 |
2021-09-13 | ₹0.50 | annually | 2021-10-20 |
2020-09-17 | ₹0.50 | annually | 2020-10-25 |
2019-09-12 | ₹1.00 | annually | 2019-10-20 |
2018-08-14 | ₹1.00 | annually | 2018-09-23 |
2017-09-18 | ₹0.60 | annually | 2017-10-26 |
2016-09-06 | ₹0.50 | annually | 2016-10-14 |
2015-09-08 | ₹0.50 | annually | |
2015-02-24 | ₹0.20 | annually | 2015-03-14 |
2014-08-13 | ₹0.50 | annually | 2014-09-27 |
2013-08-01 | ₹0.40 | annually | |
2013-02-25 | ₹0.30 | annually | 2013-03-15 |
Bliss GVS Pharma Dividend per year
Bliss GVS Pharma Dividend growth
Bliss GVS Pharma Dividend Yield
Bliss GVS Pharma current trailing twelve-month (TTM) dividend yield is 0.32%. Interested in purchasing Bliss GVS Pharma stock? Use our calculator to estimate your expected dividend yield:
Bliss GVS Pharma Financial Ratios
Bliss GVS Pharma Dividend FAQ
Other factors to consider when evaluating Bliss GVS Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bliss GVS Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bliss GVS Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bliss GVS Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bliss GVS Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bliss GVS Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bliss GVS Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bliss GVS Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bliss GVS Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bliss GVS Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bliss GVS Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.